🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial was originally designed and powered to compare biomarker modulat...
Status
Completed
Location
University of Pittsburgh Cancer Institute
Start Date
2005-11
Trial ID
NCT01515137
Treatments Being Tested
The investigators hypothesize that the combination of eflornithine and suli...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2013-08-23
Trial ID
NCT01349881
The purpose of this study is to determine the effects of 2 drugs (sulindac ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT01636128
Treatments Being Tested
The purpose of this randomized, double-blind, Phase III trial is to determi...
Status
Completed
Location
University of California San Diego
Start Date
2013-10
Trial ID
NCT01483144
Treatments Being Tested
The purpose of this study is to determine in a randomized, placebo-controll...
Status
Completed
Location
Huntsman Cancer Institute
Start Date
2010-04
Trial ID
NCT01187901
The purpose of this study is to see if a drug called sulindac can prevent t...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2006-02-23
Trial ID
NCT00299195
The primary objective of this study is to determine if sulindac at a dose o...
Status
Completed
Location
Cedars Sinai - Cancer
Start Date
2020-11-20
Trial ID
NCT04542135
Treatments Being Tested
The purpose of this study is to determine the effectiveness of curcumin in ...
Status
Terminated
Location
Cancer Institute of New Jersey
Start Date
2004-04
Trial ID
NCT00176618
This study has two purposes. One is to determine if daily sulindac decrease...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2012-12
Trial ID
NCT01761877
Treatments Being Tested
The purpose of this phase III study is to evaluate the safety and efficacy ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01245816
Treatments Being Tested